Development code · Neuroactive Steroid
UC1010
UC1010 is a development code for Sepranolone, developed by Relmada Therapeutics, Inc..
- Status
- Phase 2 for Tourette syndrome
- Mechanism
- GABA-A receptor Antagonist
- Developer
- Relmada Therapeutics, Inc.
Programs
- Sepranolone for Tourette syndromePhase 2Completed
Also known as
- Sepranolone
- Isoallopregnanolone
- Isopregnanolone
- UC-1010
- 3beta-hydroxy-5alpha-pregnan-20-one
- 516-55-2